The largest risk-directed study by a national hospital system demonstrates a 40 percent decline in bleeding events for percutaneous coronary intervention (PCI) patients and a significant reduction in pharmacy costs.
The Society for Cardiovascular Angiography and Interventions (SCAI) has released an expert consensus statement providing cardiologists, oncologists and internal medicine physicians guidance for treating patients facing concomitant cardiovascular disease and cancer.
May 6, 2016 — Cardiovascular Systems Inc. shared three-year results from its pivotal ORBIT II study in a featured ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Intact Vascular Inc. announced that positive twelve-month results from its Tack Optimized Balloon Angioplasty – Below-the-Knee (TOBA-BTK) clinical study were presented at the SCAI 2016 conference.
May 5, 2016 — The Society for Cardiovascular Angiography and Interventions (SCAI) published an update to its 2012 paper ...
Doctors and researchers at Barnes-Jewish Hospital and Washington University in St. Louis may be able to better diagnose and monitor diseases at a functional level with GE Healthcare’s next-generation SPECT/CT system, Discovery NM/CT 670 CZT.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Acutus Medical announced CE Mark approval for its AcQMap High Resolution Imaging and Mapping System and AcQMap Catheter, enabling the company to initiate commercial activities.
Today Siemens Healthcare unveiled its new brand name, Siemens Healthineers. The company said the new brand underlines Siemens Healthcare’s pioneering spirit and its engineering expertise in the healthcare industry.
Three PinnacleHealth patients recently underwent a new procedure for aortic valve reconstruction using the patients' own heart tissue (pericardium) to create the new valves.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The U.S. Food and Drug Administration (FDA) announced it is building the foundations of a national evaluation system to generate better evidence more efficiently for medical device evaluation and regulatory decision-making.
Biotronik announced U.S. Food and Drug Administration (FDA) approval of Iperia ProMRI HF-T, a cardiac resynchronization defibrillator that provides heart failure patients with access to diagnostic magnetic resonance imaging (MRI) scans.
The global market for contrast media injectors is set to increase from $830 million in 2015 to almost $1.8 billion by 2022, according to research and consulting firm GlobalData.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 3, 2016 — Good news for clinicians and their patients: the evaluation of left ventricular (LV) diastolic function ...
May 2, 2016 — Hitachi Medical Systems America Inc. announced its All-Inclusive Service and Support Program for its ...
In a recent case series, clinicians from The Heart Center at Nationwide Children’s Hospital and The Ohio State University Wexner Medical Center describe the first implantable hemodynamic monitor (IHM) placement in single-ventricle Fontan anatomy.
May 06, 2016
